Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

The Widow Maker: A National Inpatient Sample Study of Health Care Utilization Costs for Cardiovascular Complications Patients Diagnosed with Non-Hodgkin's Lymphoma from 2000-2014

Ragisha Gopalakrishnan, MD, Shruti Chaturvedi, MBBS,MS

Blood (2017) 130 (Supplement 1): 4696.

https://doi.org/10.1182/blood.V130.Suppl_1.4696.4696

Published: 2017

Journal Articles

Long-Term Follow-up of Previously Treated Patients Who Received Ibrutinib for Symptomatic Waldenstrom's Macroglobulinemia: Update of Pivotal Clinical Trial

Steven P Treon, MDPhDFRCP, Kirsten Meid, MPH, Joshua Gustine, Kurt S. Bantilan, MPH, Toni Dubeau, NP, Patricia Severns, NP, Guang Yang, PhD, Lian Xu, Christopher Patterson, MAcc, Irene M Ghobrial, MD, Jacob Laubach, MD, Zachary Hunter, PhD, Jorge J. Castillo, MD, Maria L. Palomba, MD, Ranjana H. Advani, MD

Blood (2017) 130 (Supplement 1): 2766.

https://doi.org/10.1182/blood.V130.Suppl_1.2766.2766

Published: 2017

Journal Articles

Ibrutinib Is Highly Active As First Line Therapy in Symptomatic Waldenstrom's Macroglobulinemia

Blood (2017) 130 (Supplement 1): 2767.

https://doi.org/10.1182/blood.V130.Suppl_1.2767.2767

Published: 2017

Journal Articles

A Phase 2 Study of Ofatumumab in Combination with a Pan-AKT Inhibitor (Afuresertib) in Previously Treated Patients with Chronic Lymphocytic Leukemia (CLL)

Christine I Chen, MD, Susi Snitzler, RN, Olga Levina, RN, Tong (Trina) Wang, RN, Lisa W Le, MSc, Harminder Paul, Ellen Nong Wei, Anthea Lau, Michelle Queau, James B Johnston, MD, Suzanne Trudel, MD, Deborah A Smith

Blood (2015) 126 (23): 1742.

https://doi.org/10.1182/blood.V126.23.1742.1742

Published: 2015

Journal Articles

An Open-Label Phase 2 Study Of Ofatumumab In Combination With a Novel AKT Inhibitor (Afuresertib) In Previously Treated Patients With Chronic Lymphocytic Leukemia (CLL)

Christine I. Chen, MD, Susi Snitzler, RN, Trina Wang, RN, Harminder Paul, Lisa W Le, Ellen Nong Wei, MSc, Anthea Lau, Deborah A Smith, PharmD, Michelle Brown, James B Johnston, MD, Suzanne Trudel, MD, MSC, FRCPC

Blood (2013) 122 (21): 4175.

https://doi.org/10.1182/blood.V122.21.4175.4175

Published: 2013

Journal Articles

Haploidentical Transplantation In Adults ≥ 66 Years of Age

Dolores Grosso, DNP, Onder Alpdogan, MD, Emmanuel C. Besa, MD, Matthew Carabasi, MD, Beth Colombe, PhD, Patricia Cornett Farley, BSc, Joanne Filicko-O'Hara, MD, Elena Gitelson, MD, Margaret Kasner, MD, Ubaldo Martinez-Outshoorn, MD, William O'Hara, PharmD, John L. Wagner, MD, Mark Weiss, MD, Neal Flomenberg, MD

Blood (2010) 116 (21): 3529.

https://doi.org/10.1182/blood.V116.21.3529.3529

Published: 2010

Journal Articles

Relationship of Stem Cell Transplant and Risk of Atrial Fibrillation in Multiple Myeloma: A Case-Control Study.

Morie Abraham Gertz, MD, Kaniz Fatema, MBBS, Ivana N. Micallef, MD, Amy D. Eisinger, Marion E. Barnes, Stephen S. Cha, Teresa S. Tsang, MD

Blood (2007) 110 (11): 3001.

https://doi.org/10.1182/blood.V110.11.3001.3001

Published: 2007

Journal Articles

Phase II Study of RCHOP with Pegylated Liposomal Doxorubicin (DRCOP) for Patients > 60 Years Old with Untreated Diffuse Large B Cell Lymphoma (DLBCL).

Maria Alma Rodriguez, MD, Michelle Fanale, MD, Fredrick Hagemeister, MD, Peter McLaughlin, MD, Barbara Pro, MD, Jorge Romaguera, MD, Larry Kwak, MD, Ph.D., Luis Fayad, MD, Xuelin Huang, Ph.D, Jean Bernard Durand, MD

Blood (2007) 110 (11): 4468.

https://doi.org/10.1182/blood.V110.11.4468.4468

Published: 2007

Journal Articles

Autologous Stem Cell Transplantation (ASCT) in Multiple Myeloma (MM) Patients with Dialysis-Dependent Renal Failure Is Effective but Carries High Rates of Toxicity.

Lisa Chodirker, MD, Joseph R. Mikhael, M.Ed, MD, Keith Stewart, MD, Andrew Winter, BScN, Donna E. Reece, MD, Norman Franke, MD, Suzanne Trudel, MD, Vishal Kukreti, M.Sc, MD, Wei Xu, PhD, Christine I. Chen, M.Ed, MD

Blood (2007) 110 (11): 954.

https://doi.org/10.1182/blood.V110.11.954.954

Published: 2007

Journal Articles

High Dose Celecoxib and Metronomic ‘Low-Dose’ Cyclophosphamide Is Effective Therapy in Patients with Relapsed and Refractory Aggressive Histology NHL.

Rena Buckstein, M. Crump, Y. Shaked, D. Spaner, E. Piliotis, K. Imrie, R. Nayar, C. Foden, R. Turner, D. Taylor, S. Man, S. Baruchel, D. Stempak, I. Quirt, J. Sturgeon, F. Bertolini, R.S. Kerbel

Blood (2004) 104 (11): 4622.

https://doi.org/10.1182/blood.V104.11.4622.4622

Published: 2004

NARROW

The Widow Maker: A National Inpatient Sample Study of Health Care Utilization Costs for Cardiovascular Complications Patients Diagnosed with Non-Hodgkin's Lymphoma from 2000-2014

Long-Term Follow-up of Previously Treated Patients Who Received Ibrutinib for Symptomatic Waldenstrom's Macroglobulinemia: Update of Pivotal Clinical Trial

Ibrutinib Is Highly Active As First Line Therapy in Symptomatic Waldenstrom's Macroglobulinemia

A Phase 2 Study of Ofatumumab in Combination with a Pan-AKT Inhibitor (Afuresertib) in Previously Treated Patients with Chronic Lymphocytic Leukemia (CLL)

An Open-Label Phase 2 Study Of Ofatumumab In Combination With a Novel AKT Inhibitor (Afuresertib) In Previously Treated Patients With Chronic Lymphocytic Leukemia (CLL)

Haploidentical Transplantation In Adults ≥ 66 Years of Age

Relationship of Stem Cell Transplant and Risk of Atrial Fibrillation in Multiple Myeloma: A Case-Control Study.

Phase II Study of RCHOP with Pegylated Liposomal Doxorubicin (DRCOP) for Patients > 60 Years Old with Untreated Diffuse Large B Cell Lymphoma (DLBCL).

Autologous Stem Cell Transplantation (ASCT) in Multiple Myeloma (MM) Patients with Dialysis-Dependent Renal Failure Is Effective but Carries High Rates of Toxicity.

High Dose Celecoxib and Metronomic ‘Low-Dose’ Cyclophosphamide Is Effective Therapy in Patients with Relapsed and Refractory Aggressive Histology NHL.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only